Search - tctmd.com

Displaying 461 - 480 of 1588

Sort: Relevancy | Date

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials

Presenter: Toshiki Kuno

September 17, 2022

Presentation TCT 2022

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Presenter: Roland Schmieder

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Presentation TCT 2022

First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

Presenter: David Adams

September 17, 2022

Presentation TCT 2022

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

Presenter: Zardasht Oqab

September 17, 2022

Presentation TCT 2022

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

Presenter: Kevin Bainey

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Conference News TCT 2022

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Caitlin E. Cox

September 16, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

Caitlin E. Cox

November 09, 2021

Presentation TCT 2021

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

Presenter: Martin Leon

November 06, 2021

Presentation TCT 2021

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

Presenter: Pasi Karjalainen

November 06, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

Presentation TCT 2021

Clinical Trials Paving the Way for Data

Presenter: Robert Lookstein

November 06, 2021

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Advertisement

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Clinical Trials Paving the Way for Data

DCBs in Coronaries? Some Good News, but More Work Needed

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content